tiprankstipranks
Oncimmune Holdings PLC (GB:ONC)
LSE:ONC
UK Market

Oncimmune Holdings (ONC) Income Statement

Compare
5 Followers

Oncimmune Holdings Income Statement

Last quarter (Q3 2023), Oncimmune Holdings's total revenue was £1.19M, a decrease of -17.06% from the same quarter last year. In Q3, Oncimmune Holdings's net income was £-1.10M. See Oncimmune Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Jun 22Jun 21Jun 20
Total Revenue
£ 2.74M£ 1.15M£ 3.86M£ 3.72M£ 509.00K
Gross Profit
£ 1.23M£ 792.00K£ 1.46M£ 2.86M£ -28.00K
Operating Expenses
£ 4.46M£ 5.03M£ 10.04M£ 8.00M£ 9.82M
Depreciation and Amortization
£ 263.00K£ 981.00K£ 197.00K£ 740.00K£ 500.00K
EBITDA
£ -3.00M£ -4.43M£ -7.16M£ -4.48M£ -8.97M
Operating Income
£ -3.23M£ -4.24M£ -8.59M£ -5.14M£ -9.27M
Other Income/Expenses
£ -749.00K£ -1.69M£ -943.00K£ -551.00K£ -515.00K
Pretax Income
£ -3.98M£ -5.93M£ -9.53M£ -5.70M£ -9.78M
Net Income
£ -3.63M£ 4.10M£ -9.51M£ -4.63M£ -8.46M
Per Share Metrics
£ ―£ ―£ ―£ ―£ ―
Basic EPS
£ -0.05£ 0.06£ -0.15£ -0.07£ -0.13
Diluted EPS
£ -0.05£ 0.06£ -0.15£ -0.07£ -0.13
Weighted Average Shares Outstanding
74.14M 72.51M 64.55M 64.57M 63.30M
Weighted Average Shares Outstanding (Diluted)
74.14M 72.51M 64.55M 64.57M 63.30M
Currency in GBP

Oncimmune Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis